fulvestrant - Robuta Search

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=306c283b-9abe-4985-856b-1957f1f3af8b DailyMed - FULVESTRANT injection dailymed fulvestrant injection https://pubmed.ncbi.nlm.nih.gov/28903361/ Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer... The observational prospective trial herein presented aimed at evaluating the efficacy of fulvestrant 500 mg in the treatment of endocrine sensitive advanced... endocrine therapy sensitive advanced fulvestrant milligrams https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68462-0317/ 68462-0317 Fulvestrant - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. fulvestrant ndc https://publikationen.uni-tuebingen.de/xmlui/handle/10900/129349 MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and... https://adisinsight.springer.com/trials/700365533?error=cookies_not_supported&code=6ae25a77-689b-4c8c-bc2d-31d71d9fa3d2 Milademetan and Fulvestrant in GATA3-mutant, ER-positive, HER2-negative Advanced or Metastatic... This is a single arm, multicentric phase II study of milademetan plus fulvestrant in patients with ER+, HER2- ABC harboring GATA3 mutation(s) in the tumor https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/71731-6121/ 71731-6121 Fulvestrant - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. fulvestrant ndc https://www.nice.org.uk/guidance/ta687/chapter/2-Information-about-ribociclib 2 Information about ribociclib | Ribociclib with fulvestrant for treating hormone... Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative,... information about ribociclib fulvestrant treating hormone https://adisinsight.springer.com/trials/700035443?error=cookies_not_supported&code=f2ffde25-6e9e-4abf-85cf-327b5e2220a4 A Phase II Open-Label Study of Sorafenib Plus Fulvestrant As Salvage Therapy for Hormone receptor... This phase II trial is studying how well giving sorafenib together with fulvestrant works in treating patients with locally advanced or metastatic breast cancer https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/67457-0311/ 67457-0311 Fulvestrant - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. fulvestrant ndc https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=151b948a-3106-497a-b1c7-479307faeb89&audience=consumer DailyMed - FULVESTRANT injection, solution fulvestrant injection dailymed solution https://pure.psu.edu/en/publications/fulvestrant-treatment-alters-mdm2-protein-turnover-and-sensitivit/ Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01211 Alisertib with or without Fulvestrant in Treating Patients with Locally Advanced or Metastatic,... Alisertib with or without Fulvestrant in Treating Patients with Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer without fulvestrant https://research.monash.edu/en/projects/multicenter-randomized-double-blind-placebo-controlled-phase-3-tr/ Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of Fulvestrant (Faslodex)... double blind https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.984454/full Frontiers | Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human... Cystic brain metastases in patients with breast cancer are rare. They have a worse prognosis than solid brain metastases, and they are less sensitive to radi... hormone receptor positive for the https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/43598-0262/ 43598-0262 Fulvestrant - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. fulvestrant ndc https://scholars.uky.edu/en/projects/a-phase-ii-study-of-combined-fulvestrant-fulvestrant-and-rad001-e-5/ A Phase II Study of Combined Fulvestrant (Fulvestrant) and RAD001 (Everolimus) in... phase ii study https://adisinsight.springer.com/trials/700309786?error=cookies_not_supported&code=3cb9c99b-5a83-4fd2-ac12-34c726e7a88a Pyrotinib Plus Fulvestrant in Patients HR+/HER2+ Metastatic Breast Cancer : a Prospective,... To study efficacy of pyrotinib plus fulvestrant as the therapy HR+/HER2+ metastatic breast cancer. metastatic breast cancer in patients https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/83634-0203/ 83634-0203 Fulvestrant - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. fulvestrant ndc https://www.cancerresearchuk.org/about-cancer/treatment/drugs/capivasertib-fulvestrant Capivasertib and fulvestrant | Cancer drugs | Cancer Research UK Capivasertib and fulvestrant is a treatment for breast cancer. Find out about how you have it, possible side effects and other important information. cancer drugs capivasertib fulvestrant research uk https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-palbociclib-and-fulvestrant-for-advanced-breast-cancer-that-has-continued-to-grow-despite Cancer Research UK | A study of palbociclib and fulvestrant for advanced breast cancer that has... This study looked at adding palbociclib to a hormone treatment called fulvestrant for advanced breast cancer. cancer research uk https://ce.massmed.nejm.org/nejm-weekly-cme/content/overall-survival-ribociclib-plus-fulvestrant-advanced-breast-cancer Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | MMS/NEJM Continuing... advanced breast cancer